SG11201502183XA - In vitro pancreatic differentiation of pluripotent mammalian cells - Google Patents

In vitro pancreatic differentiation of pluripotent mammalian cells

Info

Publication number
SG11201502183XA
SG11201502183XA SG11201502183XA SG11201502183XA SG11201502183XA SG 11201502183X A SG11201502183X A SG 11201502183XA SG 11201502183X A SG11201502183X A SG 11201502183XA SG 11201502183X A SG11201502183X A SG 11201502183XA SG 11201502183X A SG11201502183X A SG 11201502183XA
Authority
SG
Singapore
Prior art keywords
mammalian cells
pancreatic differentiation
pluripotent mammalian
vitro pancreatic
vitro
Prior art date
Application number
SG11201502183XA
Inventor
Ludovic Vallier
Hsin-Hua Cho
Original Assignee
Cambridge Entpr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Entpr Ltd filed Critical Cambridge Entpr Ltd
Publication of SG11201502183XA publication Critical patent/SG11201502183XA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C12N5/0678—Stem cells; Progenitor cells; Precursor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/39—Pancreas; Islets of Langerhans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5038—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites per se
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/507—Pancreatic cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/117—Keratinocyte growth factors (KGF-1, i.e. FGF-7; KGF-2, i.e. FGF-12)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/41—Hedgehog proteins; Cyclopamine (inhibitor)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
SG11201502183XA 2012-09-20 2013-09-16 In vitro pancreatic differentiation of pluripotent mammalian cells SG11201502183XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1216796.1A GB201216796D0 (en) 2012-09-20 2012-09-20 In vitro pancreatic differentiation
PCT/EP2013/069188 WO2014044646A1 (en) 2012-09-20 2013-09-16 In vitro pancreatic differentiation of pluripotent mammalian cells

Publications (1)

Publication Number Publication Date
SG11201502183XA true SG11201502183XA (en) 2015-05-28

Family

ID=47190333

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201502183XA SG11201502183XA (en) 2012-09-20 2013-09-16 In vitro pancreatic differentiation of pluripotent mammalian cells
SG10201702239XA SG10201702239XA (en) 2012-09-20 2013-09-16 In vitro pancreatic differentiation of pluripotent mammalian cells

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201702239XA SG10201702239XA (en) 2012-09-20 2013-09-16 In vitro pancreatic differentiation of pluripotent mammalian cells

Country Status (10)

Country Link
US (1) US9790470B2 (en)
EP (1) EP2898063B1 (en)
JP (1) JP6463681B2 (en)
CN (1) CN104755607B (en)
AU (1) AU2013320408A1 (en)
CA (1) CA2924511C (en)
DK (1) DK2898063T3 (en)
GB (1) GB201216796D0 (en)
SG (2) SG11201502183XA (en)
WO (1) WO2014044646A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9719068B2 (en) 2010-05-06 2017-08-01 Children's Hospital Medical Center Methods and systems for converting precursor cells into intestinal tissues through directed differentiation
US10174289B2 (en) 2014-05-28 2019-01-08 Children's Hospital Medical Center Methods and systems for converting precursor cells into gastric tissues through directed differentiation
US9371516B2 (en) 2014-09-19 2016-06-21 Regenerative Medical Solutions, Inc. Compositions and methods for differentiating stem cells into cell populations comprising beta-like cells
US11584916B2 (en) 2014-10-17 2023-02-21 Children's Hospital Medical Center Method of making in vivo human small intestine organoids from pluripotent stem cells
GB201510950D0 (en) 2015-06-22 2015-08-05 Cambridge Entpr Ltd In vitro Production of Cholangiocytes
CN106467918B (en) * 2015-08-18 2020-07-31 中国科学技术大学先进技术研究院 Induction method and application of insulin secreting cells based on human skin cells
EP3411472A4 (en) 2016-02-01 2020-01-22 Cedars-Sinai Medical Center Systems and methods for growth of intestinal cells in microfluidic devices
ES2929758T3 (en) 2016-05-05 2022-12-01 Childrens Hospital Med Ct Methods for the in vitro manufacture of gastric fundus tissue and compositions related thereto
CN107349193A (en) * 2016-05-10 2017-11-17 北京市神经外科研究所 Purposes of the protein function inhibitor DAPT in the medicine for preparing treatment endocrine system disease
KR102558606B1 (en) 2016-12-05 2023-07-26 칠드런즈 호스피탈 메디칼 센터 Colon organ organ and methods of making and using the same
SG11201906225PA (en) * 2017-01-17 2019-08-27 Agency Science Tech & Res Maintenance and expansion of pancreatic progenitor cells
WO2018140647A1 (en) 2017-01-25 2018-08-02 Cedars-Sinai Medical Center In vitro induction of mammary-like differentiation from human pluripotent stem cells
US11767513B2 (en) 2017-03-14 2023-09-26 Cedars-Sinai Medical Center Neuromuscular junction
US11414648B2 (en) 2017-03-24 2022-08-16 Cedars-Sinai Medical Center Methods and compositions for production of fallopian tube epithelium
US10767164B2 (en) 2017-03-30 2020-09-08 The Research Foundation For The State University Of New York Microenvironments for self-assembly of islet organoids from stem cells differentiation
CN111094547B (en) * 2017-06-14 2024-02-09 德国亥姆霍兹慕尼黑中心健康与环境研究中心（有限公司） Method for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells
EP3768823A4 (en) * 2018-03-23 2022-03-09 Cedars-Sinai Medical Center Methods of use of islet cells
CN112888778A (en) * 2018-10-15 2021-06-01 Cynity株式会社 Method for producing stem/progenitor cells from cells derived from an endosymbiont tissue or organ by means of a low-molecular compound
CN111607556B (en) * 2019-01-25 2022-06-07 中国科学院广州生物医药与健康研究院 Culture medium for culturing and amplifying human hepatic progenitor cells and application thereof
WO2020207998A1 (en) * 2019-04-08 2020-10-15 Novo Nordisk A/S Generation of pancreatic endoderm from stem cell derived definitive endoderm
EP3972990A4 (en) * 2019-05-22 2023-10-11 The Cleveland Clinic Foundation Generating dorsal foregut, and anterior domain, endoderm cells
KR20220098914A (en) * 2021-01-05 2022-07-12 재단법인 아산사회복지재단 Method for differentiation of insulin-producing cells using ionized atelocollagen, and artificial pancreas manufactured by the same method
CN113046299A (en) * 2021-03-19 2021-06-29 上海爱萨尔生物科技有限公司 Additive for preparing islet beta cells by inducing pluripotent stem cells to differentiate directionally
CN112961823B (en) * 2021-03-19 2024-01-23 上海爱萨尔生物科技有限公司 Culture solution for preparing islet beta cells by inducing directional differentiation of pluripotent stem cells
CN113234664A (en) * 2021-05-11 2021-08-10 澳门大学 Preparation method and application of pancreatic progenitor cells
WO2023097513A1 (en) * 2021-11-30 2023-06-08 Hangzhou Reprogenix Bioscience, Inc. Method of generating functional islets from pluripotent stem cells

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436704B1 (en) * 2000-04-10 2002-08-20 Raven Biotechnologies, Inc. Human pancreatic epithelial progenitor cells and methods of isolation and use thereof
KR101008868B1 (en) * 2001-12-07 2011-01-17 제론 코포레이션 Islet cells from human embryonic stem cells
JP5131833B2 (en) * 2005-10-05 2013-01-30 晃文 松山 Method for obtaining pancreatic endocrine cells from adipose tissue-derived cells
GB0622394D0 (en) 2006-11-09 2006-12-20 Univ Cambridge Tech Differentiation of pluripotent cells
CN101861386A (en) * 2007-07-18 2010-10-13 生命扫描有限公司 The differentiation of human embryo stem cell
CN107574142B (en) * 2007-11-27 2021-07-06 生命扫描有限公司 Differentiation of human embryonic stem cells
WO2010002785A1 (en) * 2008-06-30 2010-01-07 Centocor Ortho Biotech Inc. Differentiation of pluripotent stem cells
US9234178B2 (en) * 2008-10-31 2016-01-12 Janssen Biotech, Inc. Differentiation of human pluripotent stem cells
WO2010091241A2 (en) * 2009-02-06 2010-08-12 President And Fellows Of Harvard College Compositions and methods for promoting the generation of definitive endoderm
EP2233566A1 (en) * 2009-03-17 2010-09-29 Vrije Universiteit Brussel Generation of pancreatic progenitor cells
JP6219568B2 (en) * 2009-07-20 2017-10-25 ヤンセン バイオテツク，インコーポレーテツド Differentiation of human embryonic stem cells
SG10201502242VA (en) * 2010-03-23 2015-05-28 Kuraray Co Culture method for causing differentiation of pluripotent mammalian cells
RU2587634C2 (en) * 2010-05-12 2016-06-20 Янссен Байотек, Инк. Differentiation of human embryo stem cells
KR101877077B1 (en) * 2010-08-09 2018-07-10 다케다 야쿠힌 고교 가부시키가이샤 Method of producing pancreatic hormone-producing cells
GB201014169D0 (en) 2010-08-25 2010-10-06 Cambridge Entpr Ltd In vitro hepatic differentiation
WO2012170853A1 (en) 2011-06-10 2012-12-13 Wisconsin Alumni Research Foundation ("Warf") Methods and devices for differentiating pluripotent stem cells into cells of the pancreatic lineage

Also Published As

Publication number Publication date
SG10201702239XA (en) 2017-04-27
AU2013320408A1 (en) 2015-05-07
DK2898063T3 (en) 2019-01-28
JP6463681B2 (en) 2019-02-06
JP2015535175A (en) 2015-12-10
EP2898063A1 (en) 2015-07-29
CN104755607B (en) 2019-02-12
US9790470B2 (en) 2017-10-17
WO2014044646A1 (en) 2014-03-27
CA2924511C (en) 2021-05-25
US20150225698A1 (en) 2015-08-13
EP2898063B1 (en) 2018-11-07
CA2924511A1 (en) 2014-03-27
CN104755607A (en) 2015-07-01
GB201216796D0 (en) 2012-11-07

Similar Documents

Publication Publication Date Title
SG11201502183XA (en) In vitro pancreatic differentiation of pluripotent mammalian cells
IL288509A (en) Mammalian cell culture
HK1217727A1 (en) Suspension and clustering of human pluripotent cells for differentiation into pancreatic endocrine cells
HRP20190484T1 (en) Cell culture compositions and methods for polypeptide production
HK1199905A1 (en) Culturing of mesenchymal stem cells
HK1186492A1 (en) Differentiation of pluripotent stem cells
SG10201502242VA (en) Culture method for causing differentiation of pluripotent mammalian cells
IL214818A0 (en) Differentiation of pluripotent cells
EP2859093A4 (en) Improved methods of cell culture for adoptive cell therapy
EP2850175A4 (en) Improved methods of cell culture for adoptive cell therapy
HK1207885A1 (en) Differentiation of human embryonic stem cells into pancreatic endoderm
EP2847320A4 (en) Osteogenic differentiation of mesenchymal stem cells
SG11201500386WA (en) Cell culture of corneal endothelial cells